Futura Medical plc (Futura) is engaged in research and development of pharmaceutical drugs and medical devices and their commercial exploitation. The Company�s product includes Condoms, Erectile dysfunction, Enhanced sexual control, Pain relief, Early stage product development-CRF100 and Delivery technology. The Company has eight products in its development pipeline for sexual healthcare and pain relief, which include CSD500, PET500, MED2002, TPR100, TPR100 Rx, TIB200, SPR300 and CRF100. The Company has developed a transdermal delivery technology, DermaSys, for the absorption of active molecules through the skin. DermaSys AquaFree enables drugs that are water sensitive (hydrolytically unstable or which have only limited hydrolytic stability) to be developed into products with the additional benefit of rapid transdermal delivery.